Literature DB >> 20733508

In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms.

Romain Bazeli1, Michèle Coutard, Benjamin Daumas Duport, Eric Lancelot, Claire Corot, Jean-Pierre Laissy, Didier Letourneur, Jean-Baptiste Michel, Jean-Michel Serfaty.   

Abstract

OBJECTIVE: Abdominal aortic aneurysm (AAA) rupture is a devastating event, and development of noninvasive methods to detect AAA at risk is needed. Matrix metalloproteinases (MMPs) play a major role in AAA growth and their subsequent rupture. This study was aimed to evaluate the ability of P947, a recently developed magnetic resonance imaging (MRI) contrast agent, to target MMPs in vivo in expanding experimental AAAs.
MATERIALS AND METHODS: AAAs were induced in Wistar rats (n = 18) by perfusion of a segment of the abdominal aorta with porcine elastase. After 5 or 6 days of elastase perfusion, when the aortic segment was expanding and showed inflammation with high MMP levels, rats were injected either with P947 (n = 6), P1135, a scramble form of P947 (n = 6), or with the reference contrast agent Gadolinium-DOTA (Gd-DOTA) (n = 3). Sham-operated rats (n = 3) were injected with P947 as controls. Imaging was performed on the animals using a 1.5T MRI scanner before and at different times after injection of contrast agents (100 μmol/kg). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gelatin zymography of culture media conditioned by incubation with perfused aortic segment or control TA from elastase-perfused rats (n = 3) was performed to determine levels of MMP2 and MMP9. In addition, in situ gelatin zymography was used to localize these active MMPs on frozen histologic sections.
RESULTS: The normalized signal enhancement determined on MRI images was higher in the perfused aortic segment of rats injected with P947 (162%) than in rats injected with P1135 (100%) or Gd-DOTA (117%) (P < 0.01 using the Friedman test) from 5 to 125 minutes after injection. The area of contrast enhancement on MRI images colocalized with the fluorescence generated by MMPs in the AAA inflammatory area, as detected by in situ zymography on histologic sections.
CONCLUSION: Our data showed that MRI using P947 allows detection of MMP activity within the inflammatory wall of experimental AAAs, thus representing a potential noninvasive method to detect AAAs with a high risk of rupture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20733508     DOI: 10.1097/RLI.0b013e3181ee5bbf

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  16 in total

Review 1.  Molecular imaging of aortic aneurysms.

Authors:  Denis B Buxton
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-01       Impact factor: 7.792

2.  In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity.

Authors:  Lei Zhu; Fan Zhang; Ying Ma; Gang Liu; Kwangmeyung Kim; Xuexun Fang; Seulki Lee; Xiaoyuan Chen
Journal:  Mol Pharm       Date:  2011-11-01       Impact factor: 4.939

Review 3.  Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management.

Authors:  Reza Golestani; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2014-01-01       Impact factor: 5.952

4.  Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm.

Authors:  Reza Golestani; Mahmoud Razavian; Lei Nie; Jiasheng Zhang; Jae-Joon Jung; Yunpeng Ye; Michelle de Roo; Koen Hilgerink; Chi Liu; Simon P Robinson; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2014-12-30       Impact factor: 7.792

5.  High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Authors:  Stéphane Dumas; Vincent Jacques; Wei-Chuan Sun; Jeffrey S Troughton; Joel T Welch; Jaclyn M Chasse; Heribert Schmitt-Willich; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

6.  High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.

Authors:  Vincent Jacques; Stéphane Dumas; Wei-Chuan Sun; Jeffrey S Troughton; Matthew T Greenfield; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

Review 7.  Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.

Authors:  Dennis H M Kusters; Jan Tegtmeier; Leon J Schurgers; Chris P M Reutelingsperger
Journal:  Mol Imaging Biol       Date:  2012-10       Impact factor: 3.488

Review 8.  Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification.

Authors:  Jakub Toczek; Judith L Meadows; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

9.  Early Detection of Aortic Degeneration in a Mouse Model of Sporadic Aortic Aneurysm and Dissection Using Nanoparticle Contrast-Enhanced Computed Tomography.

Authors:  Ketan B Ghaghada; Pingping Ren; Laxman Devkota; Zbigniew Starosolski; Chen Zhang; Deborah Vela; Igor V Stupin; Eric A Tanifum; Ananth V Annapragada; Ying H Shen; Scott A LeMaire
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-04       Impact factor: 8.311

10.  MT1-MMP activatable fluorogenic probes with enhanced specificity via high-affinity peptide conjugation for tumor imaging.

Authors:  Xiuru Ji; Shuping Xie; Yan Jiao; Xiaojuan Zhang; Duxin Sun; Victor C Yang; Mei Wang; Huining He; Lu Sun
Journal:  Biomater Sci       Date:  2020-03-18       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.